Weed Inc.'s subsidiary receives hemp cultivation License for Arizona
WEED, Inc. is an early-stage cannabis holding company, which focuses on the development of cannabis-derived compounds.
top of page
CannaNews and CannabisTalks Videos
CannaNews
Cannabis, Hemp & CBD News
- Apr 9
- 6 min
Charlotte's Web partners with BAT and AJNA BioSciences to Seek FDA-approval for botanical drug
Charlotte's Web Holding is the market leader in innovative hemp extract wellness products.
- Mar 4
- 3 min
22nd Century Group (Nasdaq: XXII) closes on $21 million of debt to support growth
22nd Century utilizes advanced alkaloid plant technologies for hemp/cannabis to improve health and wellness
- Jan 25
- 2 min
Franny’s Farmacy restructures, rebrands, adds new products, and new retail locations
With 11 dispensaries in six states and partnerships in legal THC markets, Franny’s Farmacy continues to grow its reach and influence.
- Jan 19
- 1 min
CannaTalks Video: A conversation with Richard Schumacher, CEO of Pressure Biosciences
Richard Schumacher discusses the company's January 19, 2023 news release: "Pressure BioSciences Nanoemulsions Platform Forging...
- Jan 19
- 4 min
Pressure BioSciences Nanoemulsions Platform Forging Game-Changing Future for Cannabis Industry
Multiple test groups have confirmed that the UltraShear Nanoemulsion THC Oral Spray produces first effects between 1-10 minutes, often...
- Jul 29, 2022
- 3 min
HempMy Pet and Tarleton University announce positive results of their study using CBD on horses
The objective of the research program was to explore opportunities that full spectrum CBD oil may provide to the livestock industry.
- Jul 21, 2022
- 5 min
Pressure BioSciences Announces Second Contract for Toll Manufacturing of a CBD Nanoemulsion Product
The CBD Nanoemulsion Product will use Pressure BioSciences' Proprietary Ultra Shear Technology Platform Pressure BioSciences Partners...
- Jul 5, 2022
- 2 min
Mindset Pharma develops an intranasal platform formulation technology for psychedelic medicine
Mindset Pharma Inc. is a drug discovery and development company focused on creating next-generation psychedelic medicines.
- Jun 23, 2022
- 2 min
A2W Pharma and MedC Biopharma Partner to develop Cannabinoid Therapeutics
A2W is a subsidiary of Amino Chemicals of Malta, which is a subsidiary of ABA Chemicals of China, a global pharmaceutical company.
- May 28, 2022
- 4 min
FDA Warns Four Companies for Illegally Selling CBD Products Intended for Food-Producing Animals
The FDA has requested responses from the companies within 15 working days stating how they will address these violations...
- May 19, 2022
- 1 min
Vertically integrated multistate cannabis operator Ascend Wellness closes on $36.5 million of debt
This financing will support our investments in near-term growth initiatives including the expansion of our Pennsylvania assets...
- Apr 29, 2022
- 2 min
InMed seeks patents for cannabinoid analogs
Unlike natural cannabinoids isolated from the plant which are not patentable, these cannabinoid analogs are patentable.
- Apr 25, 2022
- 2 min
Tactical Relief’s CBD brand brings mental health support for those with an active lifestyle
They're meant to support the mental well-being of those in positions that stress both their physical and psychological state.
- Apr 19, 2022
- 2 min
Pressure Biosciences to provide an update on the nanoemulsification of CBD and other cannabinoids
Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions.
- Apr 18, 2022
- 2 min
Defined Research launches pioneering clinical trial to study effects of CBD formula on human sleep
Dr. Muchowski is available for in-person investor meetings and press interviews at the Benzinga Cannabis Conference, April 19-21 in Miami.
- Mar 25, 2022
- 5 min
Psychedelic and cannabinoid pharmaceutical company Incannex acquires APIRx Pharmaceuticals
Incannex is a pharmaceutical development company that is developing unique medicinal cannabis pharmaceutical and psychedlic products.
- Mar 21, 2022
- 7 min
Drug developer Benuvia which is focused on the FDA approved cannabinoid drug SYNDRO to go public
SYNDROS is FDA approved as a prescription drug for the treatment of chemotherapy-induced nausea and vomiting in cancer patients...
- Mar 17, 2022
- 2 min
Allied Corp files patent application for mushroom and cannabis compositions
The patent describes the entourage effect of both the specific psilocybin treatment period followed by a CBD derivative.
- Mar 11, 2022
- 4 min
Royal Emerald Pharmaceuticals raises $17 million to purchase a former Kmart store in California
Royal Emerald Pharmaceuticals is committed to replacing current addictive opioids by developing alternative medicines that will be safe...
bottom of page